Fisiopatología de la Cirrosis Hepática y de la Hipertensión Arterial
University of Nottingham
Nottingham, Reino UnidoUniversity of Nottingham-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2012
-
PGE2 reverses Gs-mediated inhibition of platelet aggregation by interaction with EP3 receptors, but adds to non-G s-mediated inhibition of platelet aggregation by interaction with EP4 receptors
Platelets, Vol. 23, Núm. 5, pp. 344-351
-
The role of prostanoid receptors in mediating the effects of PGE 3 on human platelet function
Thrombosis and Haemostasis
2011
-
Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 31, Núm. 2, pp. 416-422
-
Mode of action of P2Y12 antagonists as inhibitors of platelet function
Thrombosis and Haemostasis, Vol. 105, Núm. 1, pp. 96-106
-
P2Y 12 and EP3 antagonists promote the inhibitory effects of natural modulators of platelet aggregation that act via cAMP
Platelets, Vol. 22, Núm. 7, pp. 504-515
-
PGE1 and PGE2 modify platelet function through different prostanoid receptors
Prostaglandins and Other Lipid Mediators, Vol. 94, Núm. 1-2, pp. 9-16
2010
-
The role of prostanoid receptors in mediating the effects of PGE2 on human platelet function
Platelets, Vol. 21, Núm. 5, pp. 329-342